title: Pemetrexed and interstitial lung disease.
authors.affiliation: a Cancer Center and Blood Institute, St. Joseph Regional Medical Center , Lewiston , Idaho , USA and.
authors.forename: B
authors.initials: B
authors.lastname: Adhikari
authors.affiliation: a Cancer Center and Blood Institute, St. Joseph Regional Medical Center , Lewiston , Idaho , USA and.
authors.forename: R M
authors.initials: RM
authors.lastname: Dongol
authors.affiliation: b Department of Internal Medicine , SUNY Upstate Medical University , Syracuse , New York , USA.
authors.forename: D
authors.initials: D
authors.lastname: Baral
authors.affiliation: a Cancer Center and Blood Institute, St. Joseph Regional Medical Center , Lewiston , Idaho , USA and.
authors.forename: Y
authors.initials: Y
authors.lastname: Hewett
authors.affiliation: a Cancer Center and Blood Institute, St. Joseph Regional Medical Center , Lewiston , Idaho , USA and.
authors.forename: B K
authors.initials: BK
authors.lastname: Shah
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D005260:Female; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D008654:Mesothelioma / Q000188:drug therapy; D008875:Middle Aged; D000068437:Pemetrexed / Q000009:adverse effects*; D012189:Retrospective Studies; D013256:Steroids / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D013256:Steroids; D000068437:Pemetrexed